Article category

  • HOME
  • ARTICLE CATEGORY
  • Article category
Snapshot
1861
Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
Young Chang, Soung Won Jeong, Jae Young Jang
Clin Mol Hepatol. 2024;30(1):129-133.   Published online October 13, 2023
View: 1199   Download: 90
Correspondence
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2024;30(1):126-128.   Published online November 28, 2023
View: 877   Download: 31
Correspondence on Letter regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
Yee Hui Yeo, Ju Dong Yang
Clin Mol Hepatol. 2024;30(1):124-125.   Published online November 14, 2023
View: 833   Download: 34
Letter to the Editor
Changing from NAFLD to MASLD: Similar cumulative incidence of reflux esophagitis between NAFLD and MASLD
Shuhei Fukunaga, Michita Mukasa, Dan Nakano, Tsubasa Tsutsumi, Takumi Kawaguchi
Clin Mol Hepatol. 2024;30(1):121-123.   Published online December 4, 2023
View: 975   Download: 68  Crossref: 2
Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Kuo Chao Yew, Sunny H. Wong, Vincent Wai-Sun Wong, Hazel H. Oon
Clin Mol Hepatol. 2024;30(1):118-120.   Published online November 14, 2023
View: 1361   Download: 44
Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
Yiwen Zhang, Liwei Wu, Zepeng Mu, Linlin Ren, Ying Chen, Hanyun Liu, Lili Xu, Yangang Wang, Yaxing Wang, Susan Cheng, Yih Chung Tham, Bin Sheng, Tien Yin Wong, Hongwei Ji
Clin Mol Hepatol. 2024;30(1):113-117.   Published online November 10, 2023
View: 1051   Download: 61  Crossref: 1
Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
Hinpetch Daungsupawong, Viroj Wiwanitkit
Clin Mol Hepatol. 2024;30(1):111-112.   Published online October 13, 2023
View: 1055   Download: 44
Letter regarding “Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma”
Chi Hsiao, Yung-Po Liaw
Clin Mol Hepatol. 2024;30(1):109-110.   Published online October 11, 2023
View: 870   Download: 29
Original Article
1872
Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation
Ying-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng, Tzu-Haw Chen, Yi-Ling Wu, Chieh-Chang Chen, Yu-Jen Fang, Tzeng-Huey Yang, Mindie H. Nguyen, Jaw-Town Lin, Yao-Chun Hsu
Clin Mol Hepatol. 2024;30(1):98-108.   Published online December 14, 2023
View: 1304   Download: 114
1871
Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets
Yingzhou Shi, Hang Dong, Shiwei Sun, Xiaoqin Wu, Jiansong Fang, Jianbo Zhao, Junming Han, Zongyue Li, Huixiao Wu, Luna Liu, Wanhong Wu, Yang Tian, Guandou Yuan, Xiude Fan, Chao Xu
Clin Mol Hepatol. 2024;30(1):80-97.   Published online December 7, 2023
View: 2434   Download: 134
1868
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Sheng‐Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu Cheng, Guei-Ying Chen, Guo-Xiong Zhou, Wei-Lun Tsai, Chien-Neng Kao, Chih-Lang Lin, Chia-Chi Wang, Ta-Ya Lin, Chih‐Lin Lin, Wei-Wen Su, Tzong-Hsi Lee, Te-Sheng Chang, Chun-Jen Liu, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Cheng-Yuan Peng, Chun-Wei- Tsai, Chi-Yi Chen, Ming-Lung Yu
Clin Mol Hepatol. 2024;30(1):64-79.   Published online November 21, 2023
View: 1644   Download: 80
1867
Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
Clin Mol Hepatol. 2024;30(1):49-63.   Published online November 20, 2023
View: 1745   Download: 162
1864
Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity
Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim
Clin Mol Hepatol. 2024;30(1):37-48.   Published online November 13, 2023
View: 1369   Download: 122
Review
1858
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chang, Chao-Yung Wang, Chun-Yen Lin, Chung-Lieh Hung, Cheng-Yuan Peng, Ming-Lung Yu, Ting-Hsing Chao, Jee-Fu Huang, Yi-Hsiang Huang, Chi-Yi Chen, Chern-En Chiang, Han-Chieh Lin, Yi-Heng Li, Tsung-Hsien Lin, Jia-Horng Kao, Tzung-Dau Wang, Ping-Yen Liu, Yen-Wen Wu, Chun-Jen Liu
Clin Mol Hepatol. 2024;30(1):16-36.   Published online October 4, 2023
View: 2464   Download: 225
1842
Recent advances in the management of hepatocellular carcinoma
Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang
Clin Mol Hepatol. 2024;30(1):1-15.   Published online July 21, 2023
View: 4787   Download: 245  Crossref: 2
Snapshot
1843
The role of the hepatic autonomic nervous system
Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin
Clin Mol Hepatol. 2023;29(4):1052-1055.   Published online July 25, 2023
View: 1384   Download: 51
Correspondence
Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2023;29(4):1050-1051.   Published online August 29, 2023
View: 1146   Download: 32
Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”
Ji Young Ryu, Seon Ha Baek, Sejoong Kim
Clin Mol Hepatol. 2023;29(4):1048-1049.   Published online August 14, 2023
View: 1403   Download: 27
Letter to the Editor
Letter regarding “Risk factors in nonalcoholic fatty liver disease”
Abhijit Pratap, Umesh More, Pradnya Phalak, Anita Deshmukh
Clin Mol Hepatol. 2023;29(4):1046-1047.   Published online August 22, 2023
View: 1204   Download: 33  Web of Science: 1  Crossref: 1
1840
Letter regarding “Evidence-based hyponatremia management in liver disease”
Daphne J. Theodorou, Stavroula J. Theodorou, Ioannis V. Mitselos
Clin Mol Hepatol. 2023;29(4):1043-1045.   Published online July 5, 2023
View: 1356   Download: 31  Crossref: 1
Original Article
1850
Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon
Clin Mol Hepatol. 2023;29(4):1029-1042.   Published online August 29, 2023
View: 2006   Download: 99
1855
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study
Vy H. Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2023;29(4):1002-1012.   Published online September 11, 2023
View: 2022   Download: 93  Web of Science: 1
1838
Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
Hong-Kyu Kim, Sung-Jin Bae, Min Jung Lee, Eun Hee Kim, Hana Park, Hwi Seung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee, Jaewon Choe
Clin Mol Hepatol. 2023;29(4):987-1001.   Published online July 5, 2023
View: 2947   Download: 241  Web of Science: 4  Crossref: 7
Editorial
Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
Hyo-Cheol Kim
Clin Mol Hepatol. 2023;29(4):984-986.   Published online August 14, 2023
View: 1217   Download: 31
Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
Eugene Han, Yong-ho Lee
Clin Mol Hepatol. 2023;29(4):980-983.   Published online August 16, 2023
View: 1320   Download: 78
Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy
Sang Min Yoon
Clin Mol Hepatol. 2023;29(4):977-979.   Published online August 31, 2023
View: 1015   Download: 37
Adding to the confusion in more than just the name
Jacob George
Clin Mol Hepatol. 2023;29(4):973-976.   Published online September 18, 2023
View: 1208   Download: 60  Web of Science: 1  Crossref: 4

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1509
TOTAL : 1720708
Close layer